Cargill’s Animal Nutrition business and Purac, a subsidiary of CSM, announce their collaboration in the development and commercialisation of bio-based animal feed solutions. These solutions promote stronger growth and better feed conversion in suboptimal conditions in poultry production while at the same time have the potential to significantly reduce the usage of antibiotics. A first commercial product, Aloapur®, will reach the market in July of this year.
Under the collaboration, Purac, world market leader in lactic acid and lactic acid derivatives, is focusing on technology development and production of Aloapur®, while Cargill Animal Nutrition’s Provimi business, a leading global premix, specialties and feed additives supplier, is focused on application development and commercialisation of the product.
Aloapur®, a bio based animal feed solution for the improvement of the general health of animals, has been developed and patented by Purac. Aloapur® is based on Lactylates and has been developed for the first time in animal nutrition and has demonstrated to significantly improve growth and feed conversion in poultry and turkey production in particular in suboptimal conditions. The efficacy of Aloapur® has been extensively tested and demonstrated in both scientific research as well as actual production farms by Purac and Cargill.
Commercial production will start in July in a newly built production facility at the Purac site in Gorinchem, the Netherlands.
Cargill brings its animal nutrition expertise and global footprint to the partnership. Cargill’s Provimi business will develop the application and offer Aloapur® to customers to help them improve animal health and nutrition. Cargill Animal Nutrition is committed to selecting and developing innovative solutions that can significantly improve animal nutrition.
Marco Bootz, vice president chemical & pharma at Purac, comments, "CSM is developing into a leading provider of bio-based ingredients and solutions. Our collaboration with Cargill is fully in line with our strategy to develop commercially attractive bio-based alternatives using renewable and sustainable resources. This new technology, Aloapur®, for animal health is based on our core competence in lactic acid derivatives and emulsifiers. We believe that this technology has the potential to significantly reduce the usage of low dosage antibiotics as growth promoters in animal feed, without negatively impacting production. Cargill, the world leader in animal feed, will market Aloapur®, opening up a world of opportunities."
“The use of lactylates in poultry feeds is an exciting new concept in animal nutrition,” said Scott Ainslie, vice president of strategic marketing and technology at Cargill Animal Nutrition. “This technology offers a promising, innovative nutritional solution to improve broiler and turkey health and growth in suboptimal conditions; and Cargill’s Provimi business is perfectly positioned to help bring this solution to the marketplace.”
Under the collaboration, Purac, world market leader in lactic acid and lactic acid derivatives, is focusing on technology development and production of Aloapur®, while Cargill Animal Nutrition’s Provimi business, a leading global premix, specialties and feed additives supplier, is focused on application development and commercialisation of the product.
Aloapur®, a bio based animal feed solution for the improvement of the general health of animals, has been developed and patented by Purac. Aloapur® is based on Lactylates and has been developed for the first time in animal nutrition and has demonstrated to significantly improve growth and feed conversion in poultry and turkey production in particular in suboptimal conditions. The efficacy of Aloapur® has been extensively tested and demonstrated in both scientific research as well as actual production farms by Purac and Cargill.
Commercial production will start in July in a newly built production facility at the Purac site in Gorinchem, the Netherlands.
Cargill brings its animal nutrition expertise and global footprint to the partnership. Cargill’s Provimi business will develop the application and offer Aloapur® to customers to help them improve animal health and nutrition. Cargill Animal Nutrition is committed to selecting and developing innovative solutions that can significantly improve animal nutrition.
Marco Bootz, vice president chemical & pharma at Purac, comments, "CSM is developing into a leading provider of bio-based ingredients and solutions. Our collaboration with Cargill is fully in line with our strategy to develop commercially attractive bio-based alternatives using renewable and sustainable resources. This new technology, Aloapur®, for animal health is based on our core competence in lactic acid derivatives and emulsifiers. We believe that this technology has the potential to significantly reduce the usage of low dosage antibiotics as growth promoters in animal feed, without negatively impacting production. Cargill, the world leader in animal feed, will market Aloapur®, opening up a world of opportunities."
“The use of lactylates in poultry feeds is an exciting new concept in animal nutrition,” said Scott Ainslie, vice president of strategic marketing and technology at Cargill Animal Nutrition. “This technology offers a promising, innovative nutritional solution to improve broiler and turkey health and growth in suboptimal conditions; and Cargill’s Provimi business is perfectly positioned to help bring this solution to the marketplace.”
 |
| Ball-and-stick model of L -lactic acid (Photo credit: Wikipedia) |
No comments:
Post a Comment